vs

Side-by-side financial comparison of Ranpak Holdings Corp. (PACK) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

Ranpak Holdings Corp. is the larger business by last-quarter revenue ($93.7M vs $75.5M, roughly 1.2× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 2.3%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 13.7%).

Ranpak Holdings Corp. manufactures machines and paper products used in protective paper-based packing for shipping goods and merchandise for e-commerce and industry, along with automation solutions. The company is based in Concord, Ohio, and has production facilities and offices in Reno, Nevada; Kansas City, Missouri; the Netherlands; Czech Republic; Shanghai and Singapore. The paper packaging material can be used for multiple applications like wrapping, cushioning, void fill and cold chain p...

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

PACK vs PBYI — Head-to-Head

Bigger by revenue
PACK
PACK
1.2× larger
PACK
$93.7M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+25.4% gap
PBYI
27.7%
2.3%
PACK
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
13.7%
PACK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PACK
PACK
PBYI
PBYI
Revenue
$93.7M
$75.5M
Net Profit
Gross Margin
39.0%
69.3%
Operating Margin
-1.0%
22.7%
Net Margin
Revenue YoY
2.3%
27.7%
Net Profit YoY
EPS (diluted)
$-0.11
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PACK
PACK
PBYI
PBYI
Q4 25
$93.7M
$75.5M
Q3 25
$83.6M
$54.5M
Q2 25
$77.8M
$52.4M
Q1 25
$77.6M
$46.0M
Q4 24
$91.6M
$59.1M
Q3 24
$78.6M
$80.5M
Q2 24
$72.8M
$47.1M
Q1 24
$72.5M
$43.8M
Net Profit
PACK
PACK
PBYI
PBYI
Q4 25
Q3 25
$-10.4M
$8.8M
Q2 25
$-7.5M
$5.9M
Q1 25
$-10.9M
$3.0M
Q4 24
Q3 24
$-8.1M
$20.3M
Q2 24
$5.5M
$-4.5M
Q1 24
$-8.1M
$-4.8M
Gross Margin
PACK
PACK
PBYI
PBYI
Q4 25
39.0%
69.3%
Q3 25
41.1%
77.7%
Q2 25
37.1%
76.5%
Q1 25
39.8%
77.1%
Q4 24
45.2%
76.4%
Q3 24
43.8%
63.9%
Q2 24
43.5%
77.4%
Q1 24
44.6%
75.5%
Operating Margin
PACK
PACK
PBYI
PBYI
Q4 25
-1.0%
22.7%
Q3 25
-6.8%
17.6%
Q2 25
-12.5%
12.7%
Q1 25
-10.3%
8.7%
Q4 24
1.5%
22.6%
Q3 24
-5.3%
27.4%
Q2 24
-7.1%
-4.6%
Q1 24
-6.6%
-5.3%
Net Margin
PACK
PACK
PBYI
PBYI
Q4 25
Q3 25
-12.4%
16.2%
Q2 25
-9.6%
11.2%
Q1 25
-14.0%
6.5%
Q4 24
Q3 24
-10.3%
25.2%
Q2 24
7.6%
-9.6%
Q1 24
-11.2%
-11.0%
EPS (diluted)
PACK
PACK
PBYI
PBYI
Q4 25
$-0.11
$0.26
Q3 25
$-0.12
$0.17
Q2 25
$-0.09
$0.12
Q1 25
$-0.13
$0.06
Q4 24
$-0.13
$0.40
Q3 24
$-0.10
$0.41
Q2 24
$0.07
$-0.09
Q1 24
$-0.10
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PACK
PACK
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$63.0M
$97.5M
Total DebtLower is stronger
$401.9M
$22.7M
Stockholders' EquityBook value
$534.9M
$130.3M
Total Assets
$1.1B
$216.3M
Debt / EquityLower = less leverage
0.75×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PACK
PACK
PBYI
PBYI
Q4 25
$63.0M
$97.5M
Q3 25
$49.9M
$94.4M
Q2 25
$49.2M
$96.0M
Q1 25
$65.5M
$93.2M
Q4 24
$76.1M
$101.0M
Q3 24
$69.5M
$96.7M
Q2 24
$65.1M
$96.8M
Q1 24
$55.1M
$107.2M
Total Debt
PACK
PACK
PBYI
PBYI
Q4 25
$401.9M
$22.7M
Q3 25
$403.1M
$34.0M
Q2 25
$403.1M
$45.3M
Q1 25
$405.2M
$56.7M
Q4 24
$406.4M
$68.0M
Q3 24
$403.2M
$79.3M
Q2 24
$396.1M
$90.7M
Q1 24
$396.7M
$102.0M
Stockholders' Equity
PACK
PACK
PBYI
PBYI
Q4 25
$534.9M
$130.3M
Q3 25
$537.8M
$115.3M
Q2 25
$539.0M
$104.7M
Q1 25
$544.1M
$97.1M
Q4 24
$548.1M
$92.1M
Q3 24
$564.3M
$71.1M
Q2 24
$566.2M
$48.5M
Q1 24
$560.0M
$51.0M
Total Assets
PACK
PACK
PBYI
PBYI
Q4 25
$1.1B
$216.3M
Q3 25
$1.1B
$202.9M
Q2 25
$1.1B
$194.9M
Q1 25
$1.1B
$196.2M
Q4 24
$1.1B
$213.3M
Q3 24
$1.1B
$220.7M
Q2 24
$1.1B
$205.0M
Q1 24
$1.1B
$214.1M
Debt / Equity
PACK
PACK
PBYI
PBYI
Q4 25
0.75×
0.17×
Q3 25
0.75×
0.30×
Q2 25
0.75×
0.43×
Q1 25
0.74×
0.58×
Q4 24
0.74×
0.74×
Q3 24
0.71×
1.12×
Q2 24
0.70×
1.87×
Q1 24
0.71×
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PACK
PACK
PBYI
PBYI
Operating Cash FlowLast quarter
$19.5M
$14.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PACK
PACK
PBYI
PBYI
Q4 25
$19.5M
$14.4M
Q3 25
$8.5M
$9.7M
Q2 25
$-3.6M
$14.1M
Q1 25
$-1.3M
$3.6M
Q4 24
$6.5M
$15.6M
Q3 24
$10.1M
$11.0M
Q2 24
$19.6M
$1.0M
Q1 24
$5.2M
$11.2M
Free Cash Flow
PACK
PACK
PBYI
PBYI
Q4 25
$14.4M
Q3 25
$9.7M
Q2 25
$14.1M
Q1 25
$3.6M
Q4 24
$15.6M
Q3 24
$11.0M
Q2 24
$1.0M
Q1 24
FCF Margin
PACK
PACK
PBYI
PBYI
Q4 25
19.1%
Q3 25
17.7%
Q2 25
26.8%
Q1 25
7.7%
Q4 24
26.4%
Q3 24
13.7%
Q2 24
2.1%
Q1 24
Capex Intensity
PACK
PACK
PBYI
PBYI
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
PACK
PACK
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
3.56×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PACK
PACK

Other$47.9M51%
Europe And Asia Segment$45.8M49%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons